DAN JONES and ANIL PARWANI were recruited to serve in leadership roles for specialized pathology services offered across The Ohio State University Wexner Medical Center.
Jones will serve as vice chair and director of molecular pathology in the Department of Pathology and as director of molecular pathology for The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Parwani, was appointed vice chair and director of anatomic pathology in the Department of Pathology. In addition, Parwani will serve as the director of a new shared core facility focused on digital pathology imaging and pathology informatics.
Jones most recently served as medical director of cancer diagnostics devices at the Quest Diagnostics Nichols Institute, where his group was responsible for the development of more than 100 oncology, genomics and pathology assays. Previously, at MD Anderson Cancer Center, he was a tenured professor overseeing a research laboratory and the clinical molecular diagnostics team that served 13 cancer care centers. In this role, he also designed molecular monitoring protocols for clinical trials.
Jones has authored more than 250 scientific manuscripts and book chapters, emphasizing advanced diagnostics and the molecular basis of leukemia and lymphoma as well as molecular modeling of outcome and response to standard therapies in colon cancer, melanoma and other solid tumors.
Parwani arrives from the University of Pittsburgh, where he served as a professor of pathology and biomedical informatics and director of the division of pathology informatics.
In his new role as vice chair and director of anatomic pathology, Parwani will focus on automation and standardization of anatomical pathology operations including implementation of bar coding and tracking solutions within the laboratory information system.
At OSUCCC-James, Parwani will direct the digital pathology service focused on expanding precision cancer diagnostics and treatment. Parwani has published more than 250 peer-reviewed articles and several books and book chapters focused on the digital pathology, pathology informatics, diagnostic and prognostic markers in genitourinary pathology and molecular classification of kidney cancer.
